CORDITE: The Curated CORona Drug InTERactions Database for SARS-CoV-2

Since the outbreak in 2019, researchers are trying to find effective drugs against the SARS-CoV-2 virus based on de novo drug design and drug repurposing. The former approach is very time consuming and needs extensive testing in humans, whereas drug repurposing is more promising, as the drugs have already been tested for side effects, etc. At present, there is no treatment for COVID-19 that is clinically effective, but there is a huge amount of data from studies that analyze potential drugs. We developed CORDITE to efficiently combine state-of-the-art knowledge on potential drugs and make it accessible to scientists and clinicians. The web interface also provides access to an easy-to-use API that allows a wide use for other software and applications, e.g., for meta-analysis, design of new clinical studies, or simple literature search. CORDITE is currently empowering many scientists across all continents and accelerates research in the knowledge domains of virology and drug design.

Abstract licence: CC BY-NC-ND

1. 8.

   SARS coronavirus papain-like protease inhibits the type I interferon signaling pathway through interaction with the STING-TRAF3-TBK1 complex · 2014

2. 15.

   Return of the Coronavirus: 2019-nCoV · 2020

3. 16.

   A pneumonia outbreak associated with a new coronavirus of probable bat origin · 2020

4. 21.

   Coronavirus disease 2019: What we know? · 2020

5. 22.

   The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status · 2020

6. 23.

   Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors · 2020

7. 26.
   Corrected

   Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV · 2020

8. 28.

   Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir · 2020

9. 33.

   Exploring the SARS-CoV-2 virus-host-drug interactome for drug repurposing · 2020

10. 34.

    TMPRSS2 and furin are both essential for proteolytic activation of SARS-CoV-2 in human airway cells · 2020

30 more references, whose wording the paper’s licence keeps private.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.